Dabigatran Etexilate Production Process Report: Cost Model, Pre-feasibility and Industrial Trends
Dabigatran etexilate is a novel oral anticoagulant (NOAC) used in the prevention and treatment of thromboembolic disorders such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). It is a prodrug that, once metabolised in the body, becomes dabigatran, an active substance that directly inhibits thrombin, preventing blood clots. The production process of […]